Lung cancer [NEW TOPIC PAGE]

Main|Search|PHGKB



From National Institutes of Health Web Sites

---

• Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options 
• Asbestos-Related Lung Diseases 
  From NHBLI health topic site
• Bringing Precision to Screening for Cancer 
• Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches 
• FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer 
• https://www.cancer.gov/news-events/cancer-currents-blog/2019/early-stage-lung-cancer-biomarker
  NCI, January 3, 2019
• Idiopathic Pulmonary Fibrosis
  From NHBLI health topic site
• Most cases of lung cancer are due to smoking; however, there are other risk factors including family history. 
• Noninvasive strategies for lung cancer testing 
  NIH Research Matters, March 7, 2017
• Targeted Photoimmunotherapy Approach for Cancer Moves Forward 
• Two-Drug Combination Approved for Lung Cancers with BRAF Mutations
  NCI, July 18, 2017
• Using Gene Expression to Diagnose Lung Cancer More Accurately 
• With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung Cancer